Related Experiment Video
Updated: Jul 5, 2026
05:10
Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
Published on: December 11, 2016
New drug update: 2007.
1Philadelphia College of Pharmacy, University of the Sciences in Philadelphia, Pennsylvania, USA.
Summary
This study introduces a novel rating system to compare five new drugs against existing therapies. It evaluates the properties, advantages, and disadvantages of each new agent, including their use in elderly patients.
Area of Science:
- Pharmacology
- Drug Evaluation
- Geriatric Medicine
Background:
- The development of new pharmaceutical agents necessitates comprehensive evaluation against established treatments.
- Understanding the unique properties and clinical utility of novel drugs is crucial for therapeutic decision-making.
Purpose of the Study:
- To introduce and apply a unique rating system for comparing five new drugs with existing therapies.
- To evaluate the key properties, advantages, and disadvantages of each new pharmaceutical agent.
- To specifically assess the suitability and application of these new drugs in the elderly population.
Main Methods:
- Development of a novel rating system for drug comparison.
- Systematic evaluation of five new drugs based on predefined criteria.
- Comparative analysis against existing therapeutic options.
- Inclusion of geriatric considerations in the assessment.
Main Results:
- The rating system provides a structured comparison of new drug agents.
- Key properties, benefits, and drawbacks of each new drug are identified.
- The system highlights the specific utility and considerations for using new drugs in elderly patients.
Conclusions:
- The developed rating system offers a valuable tool for assessing new drugs.
- This systematic approach aids in understanding the comparative value and appropriate use of novel therapies.
- The evaluation framework is particularly relevant for guiding the use of new medications in geriatric care.
Related Concept Videos
01:26FDA Approved Drugs: Changes to Approved Drugs
Post-approval, manufacturers may modify an approved new or generic drug product. Such modifications can encompass alterations in the Active Pharmaceutical Ingredient (API), manufacturing process, formulation, batch size, manufacturing site, and container closure system (FDA Guidance for Industry, April 2004). Often, a drug product may undergo multiple changes.These modifications require careful evaluation to determine their potential impact on the drug product's identity, strength, quality,...
01:19Modified-Release Drug Delivery Systems: Overview
Modified-release dosage forms are designed to address the limitations of drugs with short biological half-lives. These forms maintain stable therapeutic drug concentrations over extended periods, reducing the need for frequent dosing. A consistent drug level helps minimize peak-trough fluctuations, which can reduce adverse effects, lower the risk of drug resistance, and improve overall treatment effectiveness.One common type of modified-release form is the extended-release (ER) formulation. ER...
01:15Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure (CHF).
01:26Drug Administration and Therapy Phases: Overview
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
01:19Modified-Release Drug Delivery Systems: Rate-Programmed II
Rate-programmed drug delivery systems release drugs in a controlled manner to maintain therapeutic levels. Three main designs include reservoir, matrix, and hybrid systems.Reservoir systems consist of a drug core enclosed within a membrane that controls drug release. In non-swelling reservoir systems, polymers like ethyl cellulose or polymethacrylates are used. These do not hydrate in aqueous media and control release through membrane thickness, porosity, or insolubility. This type includes...
01:16Therapeutic Drug Monitoring: Overview and Classification
Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood at designated intervals to ensure the drug concentration stays within a therapeutic range. This monitoring is crucial for optimizing individual dosage regimens, enhancing therapeutic efficacy, and minimizing drug-related toxicity. TDM is vital for drugs with narrow therapeutic windows, significant variability in pharmacokinetics, and a clear correlation between plasma levels and...